29.4 C
Vientiane
Saturday, May 31, 2025
spot_img
Home Blog Page 2625

TÜV Rheinland Hosts Webinar Bringing Together Stakeholders to Address the Textile Microplastics Challenge

HONG KONG SAR – Media OutReach – 3 December 2021 – On 16 November, the international independent third-party testing, inspection and certification organization TÜV Rheinland organized this webinar with the support from Invest Hong Kong, and German Chamber of Commerce, Hong Kong (GCC) to address the microplastics challenge along the global textile and garment supply chain.

Link to Youtube video

 

Among the webinar speakers were:

Rakesh Vazirani, Head of Sustainability Services, Business Stream Products, TÜV Rheinland together with

Emily Choi, Senior Manager of Consumer Products, Invest Hong Kong,

Dr. Lei YAO (Gloria), Director of Project Development, The Hong Kong Research Institute of Textiles and Apparel (HKRITA),

Dr. Frank Lam, Assistant Professor of Engineering Education, Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology (HKUST),

Dr. Cindy Lam, Lecturer, Department of Ocean Science, The Hong Kong University of Science and Technology (HKUST), and

Gundolf Klaehn, Head of Environmental Component, Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH.

Mr. Bjoern Lindner, President of the GCC, stated in the opening speech that the German business community has long placed significant emphasis on sustainability and protection of our natural world at its core. One-third of the GCC members come from the supply chain industry, and are happy to see how all stakeholders work together to address the microplastics issue.

 

TÜV Rheinland shared background and summaries on its textiles-microplastics research/initiatives and introduced the concept of linking data about microplastics shedding at the pre-consumer stage, the fabric composition/design stage, and what is detected during testing at the garment/fabric level (as per TMC, AATCC methods).

 

According to the International Union for Conservation of Nature (IUCN), 35% of the ocean’s microplastics come from synthetic textiles. Microplastics shedding at the finished product level can be correlated with microplastics shedding at the pre-consumer stage in production processes depending on wet processes, fiber construction depending, fiber composition, etc. The full related data could perhaps tell a story to designers and manufacturers that they be able to configure their production processes in order to eliminate microplastics shedding, so the idea is to combine consumer stage data with pre-consumer stage data.

 

Dr. Cindy Lam and Dr. Frank Lam from HKUST developed the Smart Fish for real-time detection of microplastics in the ocean. The Smart Fish aims to replace lab-based testing for microplastics, which can be used in the future for different scenarios, including the textile industry.

 

Dr. Gloria Yao from HKRITA spoke about an ongoing project for microplastic fibre separation through sweeping acoustic waves. It expects the project at industrial scale, to agglomerate the filtered microplastic to form a cluster in macroscopic scale to provide convenience for any feasible after-treatment.

 

Gundolf Klaehn from GIZ introduced the Promoting Sustainability in the Textile and Garment Industry on Asia (FABRIC) program, which supports initiatives and innovation fostering the transitional change of the sector with the focus on reduction of harm to the environment and improving labour and living conditions.

 

In his closing remarks, KC Lam, Head of Consulate and Chamber Engagement, Invest Hong Kong stated: “We have started to educate the consumer on microplastics. They will soon be demanding better and higher standards for companies to live up to.”  Microplastics have become a plastic pollutant of oceans on a global scale. Shaping solutions will include approaches based on detection and removal, product design and lifecycle thinking, as well as the involvement of key stakeholders.

TÜV Rheinland, as a trusted partner providing a suite of assurance services affecting interactions between people, technology, and the environment, will facilitate the development and implementation of these solutions.

 

#TÜVRheinland

Laos Confirms 1,004 New Cases of Covid-19 and Five Deaths

Salavanh Covid-19 Update


Laos has recorded 1,004 cases of Covid-19 across the country today, with five deaths recorded.

Capricorn Foundation: Stablecoin Is Making Waves in Traditional Economy

KUALA LUMPUR, MALAYSIA – Media OutReach – 3 December 2021 – Crypto has had futures for some times and only recently has its structure developing more sophisticated in the traditional financial ecosystem. In early 2019, there was only $275 million of crypto collateral locked in the DeFi economy while it hits the milestone high of $200 billion today.

 

With the announcement of Facebook rebranding itself into “Meta”, which referred to metaverse, a virtually-reality platform. More traditional giants are fastening their pace into “decentraland”. Stablecoin, which designed to maintain a stable value relative to a national currency or other reference assets, is making its waves in global traditional economy.

 

“Although Bitcoin and Ethereum are currently the dominant cryptocurrencies, their prices fluctuate, which will hinder real-world adoption,” said Eric from Capricorn Foundation”while emerging with the traditional finance sector,  neither businesses nor consumers want to face unnecessary risks. What I can foresee right now, for the adoption of crypto into real world business is stablecoin, and its advantages of being stable, reliable will definitely redefine our finance ecosystem.”

Malaysia-based finance solution team has just release their concept of adopting stablecoin concept into real world finance with their Capricorn Protocol, which actively cooperates with various DeFi applications, such as lending, that has stable currency usage scenarios. Using collateral as value support, the Capricorn Protocol will fully utilize its advantages to empower traditional business.

 

DHL Global Forwarding launches new two-way rail service between Kunming, China and Vientiane, Laos

  • DHL, the first international forwarder, commences pioneering operations on the brand new China-Laos railway
  • Relief for peak season logistics rates with costs up to 50% less than airfreight with similar transit times
  • Vientiane and Kunming are well-positioned as multimodal hubs for China-ASEAN trade

SHANGHAI, CHINA – Media OutReach – 3 December 2021 – DHL Global Forwarding, the leading international freight specialist division of Deutsche Post DHL Group,  is the first international forwarder to launch a two-way rail freight service between Kunming, China and Vientiane, Laos, via the newly opened China-Laos railway. The rail service is first-of-its-kind in the market, shortening transit time between Kunming and Vientiane from two days via road to about  20 – 24 hours.

DHL’s new two-way rail service will cut transit time between Kunming and Vientiane from 2 days to 20-24 hours

Faster, cheaper freight between China and Southeast Asia

 

Rail-truck solution between China & Southeast Asia: Hubs in Kunming and Vientiane

“The China-Laos Railway is a historic moment for the region. It strategically places Kunming as a hub for the Indochina market as the gateway to ASEAN economies,” said Steve Huang, CEO, DHL Global Forwarding Greater China. “ASEAN has a combined GDP of US$2.55 trillion and is predicted to be the fourth largest single market in the world by 2030. We see a very bright future for trade and economic activity in the region, which will translate to increased demand for logistics.”

 

“China is ASEAN’s largest trading partner, growing close to 40% year on year. The new rail service connecting China and Laos will transform Laos from a land-locked country to a land-linked hub, creating closer trade linkages between Laos and China, and to all economies in the Belt and Road Initiative (BRI), including ASEAN. Businesses moving goods between China and ASEAN countries now have a strong viable alternative between air and ocean freight, and can tap further into DHL’s robust road freight and multimodal network in the Southeast Asia region,” Thomas Tieber, CEO, DHL Global Forwarding Southeast Asia said.

 

Peak season relief: Faster, Cheaper freight from China to ASEAN – Costs up to 50% less than airfreight, with similar or faster transit times
Leveraging the new railway, DHL’s scheduled service runs in both directions between China and ASEAN markets, including Thailand, Vietnam, Cambodia, Malaysia, Singapore and Indonesia, providing an attractive, highly cost efficient alternative in a time when logistics costs are at an all time high.

The two-way service combines trucking from all over China to the hub in Kunming, running through the China-Laos railroad, then onward with DHL’s established road network service  and back, with significant cost savings and competitive transit times, providing a viable transportation alternative. Examples of the services include:

  • Chengdu – Bangkok – road/rail services are 78% cheaper and 2 days faster than airfreight
  • Kuala Lumpur – Chengdu – road/rail services are 70% cheaper, same transit time compared to airfreight
  • Shanghai – Singapore – road/rail services are 38% cheaper, 4 days longer compared to airfreight

The brand new China-Laos Railway is one of the six international economic corridors under China’s Belt and Road Initiative (BRI). The Laos section of the railway is 414-km that connects Kunming (China) to Boten, Laos’ northern border with China, to Vientiane in the south, on its border with Thailand. The route will cut the journey time from Vientiane to the Chinese border to less than four hours, compared to 15 hours by road. At Boten, the railway will connect with the BRI network at Kunming, China, through another 595-km railway link, providing Laos with a land link to global and regional supply chains.

 

Note to editors:

Find out more about DHL’s road and multimodal logistics offerings, with its road freight services on the rise in Southeast Asia, and a rail freight service from Xi’an in China to Hamburg and Neuss in Germany, that cut transit time down by over 40 percent.  Read more on DHL’s Logistics of Things.

 

DHL – The logistics company for the world

DHL is the leading global brand in the logistics industry. Our DHL divisions offer an unrivalled portfolio of logistics services ranging from national and international parcel delivery, e-commerce shipping and fulfillment solutions, international express, road, air and ocean transport to industrial supply chain management. With about 400,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global sustainable trade flows. With specialized solutions for growth markets and industries including technology, life sciences and healthcare, engineering, manufacturing & energy, auto-mobility and retail, DHL is decisively positioned as “The logistics company for the world”.

DHL is part of Deutsche Post DHL Group. The Group generated revenues of more than 66 billion euros in 2020. With sustainable business practices and a commitment to society and the environment, the Group makes a positive contribution to the world. Deutsche Post DHL Group aims to achieve zero-emissions logistics by 2050.

#DHL

Laos Records Trade Deficit of USD 45 Million in October

Bolaven plateau
Bolaven plateau (Photo: Champa Meuanglao)


Laos recorded a trade deficit of USD 45 million in October with imports and exports totaling USD 819 million.

Carousell Partners With NVPC For SG Cares Giving Week For The Third Time, Expanding The Company’s Commitment To Support Communities In Need

Carousell launches charity drive and commits to a quarter of million dollars worth of ad inventory to support non-profit organisations in Singapore

SINGAPORE – Media OutReach – 3 December 2021 – As Singapore’s leading classifieds platform, Carousell today announced two initiatives to support individuals and communities in need, encouraging all to share in the spirit of giving during this festive season: #Blessings campaign and Free Ads for Charities.

As part of these initiatives, Carousell has partnered with the National Volunteer & Philanthropy Centre (NVPC) to support SG Cares Giving Week with its annual #Blessings campaign. This year’s #Blessings campaign will expand its reach to bring greater awareness to the public to support local communities in need. From now to December 31, interested donors can log on to Carousell and browse listings from over 20 charities and non-profit organisations, and give back to those who need it the most by donating essential items such as home appliances, Covid-19 test kits, clothes and food, or even make direct donations to their favourite causes via Carousell Protection. Users can also list their usable items on Carousell under its Free Items category to help other individuals in need.

“The #Blessings campaign is the missing link for charity drives in Singapore to reach out to Singaporeans with ready intent to give away items. #Blessings originally started as a user-led initiative, and has grown into one adopted by our wider Carousell community over the years. With every 1 in 3 Singaporeans using Carousell monthly, we are the perfect platform to connect charities with users who are looking to declutter their surplus purchases by giving back to those who need them the most. We are excited to partner with NVPC for SG Cares Giving Week and we encourage every donor to give generously and make a positive difference this festive season.” said Ng Chee Soon, Managing Director, Carousell Singapore.

 

“We are pleased to partner Carousell once again in this meaningful campaign. Carousell offers a unique way for non-profit organisations like the Singapore Red Cross to garner both monetary and in-kind donations via a single platform. The publicity support given is also invaluable to our outreach efforts. We are hopeful that this partnership with Carousell would help us to enhance our online presence and reach a younger, more technologically-savvy audience; and in turn boost our fundraising efforts. We look forward to nurturing an enduring partnership with Carousell,” said Mr Benjamin William, Secretary General and CEO, Singapore Red Cross.

This campaign is an expansion of Carousell’s #SayYesToBlessings initiative, launched in August 2021 to help empower non-profit organisations in digitalising and amplifying their causes online. Participating charities received a complimentary CarouBiz Charities Package worth over $1,500 that includes a suite of premium promotional tools designed to help. Through this initiative, donors will also be able to make direct donations to these organisations, with 100% of the donation going directly to them.

 

Since the pandemic started, charities have been unable to organise traditional fundraising events and engage with potential donors. To help counter this challenge, Carousell is bringing back its Free Ads for Charities initiative, and will offer up to a quarter of million dollars in an advertising support programme to support charities impacted by Covid-19.

 

This $250,000 fund will focus on supporting any charities and non-profit organisations in Singapore and their efforts to replenish supply of essential items, donations for upkeep cost, call for volunteers and other initiatives caring for vulnerable communities.

 

“We are very proud to bring back our Free Ads for Charities initiative and expand upon our commitment to uplift local communities in need. Charity donations have been impacted as fundraising events have had to be cancelled due to restrictions related to the Covid-19 pandemic. With 1 in 3 Singaporeans on our platform every month, we can help amplify their causes and give these charities more visibility on the road to recovery,” said JJ Eastwood, Managing Director, Carousell Media Group.

 

These two campaigns are the latest in Carousell’s initiatives to support and empower communities during the COVID-19 situation, other initiatives include #MADEinSG to support the local art scene amid the circuit breaker period. Carousell was also recognised as a Champion of Good in 2020 by NVPC’s Company of Good.

 

Interested non-profit organisations can also reach out to Carousell here for more information.

About Carousell Group

Carousell Group is the leading classifieds group in Greater Southeast Asia on a mission to inspire the world to start selling, and to make secondhand the first choice. Founded in August 2012 in Singapore, the group has a leading presence in eight markets under the brands Carousell, Mudah.my, Cho Tot, OneKyat and Ox Street, serving tens of millions of monthly active users. Carousell is backed by leading investors including Telenor Group, Rakuten Ventures, Naver, STIC Investments and Sequoia Capital India. Visit here for more information.

About SG Cares Giving Week 2021
SG Cares Giving Week is an anchor initiative of the national SG Cares movement held annually from 1 to 7 December, that celebrates the spirit of giving and seeks to make giving part of our way of life.

Jointly organised by the National Volunteer & Philanthropy Centre, the National Council of Social Service, and the SG Cares Office, SG Cares Giving Week aims to inspire individuals, businesses, non-profit organisations and the community to give their best for others by sharing their Time, Talent, Treasure and Voice in support of any cause they are passionate about in all ways, big and small.

These are the little acts, when multiplied by millions, that make a world of difference. Together, let’s build a Singapore that cares! Take action and support the SG Cares Giving Week, visit www.givingweek.sg.

#CarousellGroup

Laos Issues New Regulations on National Dress

National dress worn 100 years ago by a member of the royal family in Luang Prabang, and now part of the private collection of Kualao restaurant
National dress worn 100 years ago by a member of the royal family in Luang Prabang, and now part of the private collection of Kualao Restaurant.

Laos has issued a decree on national dress that outlines the details of traditional clothing to be worn during ceremonial events.

Fosun Pharma Participates in the BEYOND Expo

Presents innovation-driven ecological layout of the healthcare industry

MACAO SAR – Media OutReach – 3 December 2021 – From 2 to 4 December, 2021, focusing on technology innovation and its impact on various industries to the society, the first BEYOND International Technology Innovation Expo (“BEYOND Expo”) in Macao is held at the Venetian Macao Convention and Exhibition Centre. Focusing on cutting-edge technology, Fosun Pharma together with its member enterprises in the sectors covering pharmaceutical manufacturing, medical devices and healthcare services to join the life science exhibition (Booth No.: B07). Fosun Pharma’s innovation-driven ecological layout as well as its breakthroughs and advancements of the healthcare industry are well presented.

 

 

Mr. Ho Iat Seng, Chief Executive of Macao SAR visited the Fosun Pharma booth.

 

Wu Yifang, Chairman and CEO of Fosun Pharma said: “The successful hosting of the BEYOND Expo in Macao demonstrates the Macao Special Administrative Region Government’s confidence in the results of anti-pandemic and its high-level organizational capabilities. Fosun Pharma is glad to participate in this innovative technology event, by bringing a variety of products in the anti-tumor field and the display of innovative achievements with international cooperation. In the future, we will further release our energy on the healthcare innovation in this region, continue to optimize the operational efficiency of the healthcare services business, accelerate the construction of advantageous disciplines, and promote the high-quality development of the healthcare industry in the Greater Bay Area. Oriented towards patient needs, we will also improve the accessibility of the world’s leading medical products and services in China, so that every family could enjoy good health. “

 

Deeply cultivating the oncology field, creating a number of FIRST influential products in the industry

 

Fosun Pharma is committed to promoting innovative R&D with its pharmaceutical business as its core, and is oriented towards fulfilling unmet clinical needs and improving products’ accessibility, accelerating the implementation of innovative technologies and products. At the BEYOND Expo, Fosun Pharma presents a variety of self-developed and co-developed drugs in the oncology field. After over a decade of continuous investment, Fosun Pharma has ushered in a number of products in the anti-tumor field that have been approved in recent years. At the same time, Fosun Pharma continues to increase the product accessibility in various ways to benefit more patients.

  

As the biopharmaceutical platform of Fosun Pharma, Henlius has always been committed to offering high-quality innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Henlius brings a variety of R&D achievements in the anti-tumor field and its diversified products to the BEYOND Expo, including three products that have been approved for marketing: the China’s first biosimilar Han Li Kang (Rituximab), the first self-developed Chinese mAb biosimilar entering both the EU and China market Han Qu You (Trastuzumab), the company’s first product indicated for the treatment of autoimmune diseases Han Da Yuan (Adalimumab).

 

At the same time, Henlius also brings the novel anti-PD-1 mAb Serplulimab independently developed by the company which has been approved for clinical trials in China, the United States, the European Union and other countries and regions. The indications cover a wide range of tumor types with high incidence such as lung cancer, esophageal cancer, hepatocellular cancer, gastric cancer and head and neck cancer, with around 2,300 patients have been enrolled globally. The NDA for the treatment of microsatellite instability-high (MSI-H) solid tumors has been accepted by the National Medical Products Administration (NMPA) and proposed to be granted priority review in April 2021. It is expected to be approved for marketing in the first half of 2022. Besides, the NDA filing of the first-line treatment of squamous non-small cell lung cancer (sqNSCLC) has been accepted by NMPA in September 2021.

 

In June 2021, the first CAR-T cell therapy Yi Kai Da (Axicabtagene Ciloleucel) of Fosun Kite, a joint venture, has been approved for marketing by NMPA, which was China’s first CAR-T therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, opening a new era of cell therapy in China. After its launch, the drug has achieved certain breakthroughs in patient access and clinical benefits, CAR-T academic communications, and exploration of new indications in the commercialization stage of the drug in China. In terms of payment innovation, the drug has been included in commercial insurances and customized insurances in many cities.

 

Deploy cutting-edge mRNA vaccine, responding to variations of the virus actively

 

At the BEYOND Expo, Fosun Pharma presents the COVID-19 mRNA vaccine BNT162b2, which was jointly developed with BioNTech. It has been known as the first COVID-19 mRNA vaccine approved by U.S. Food and Drug Administration (FDA), and expanded the emergency use authorization of a booster dose to include individuals 18 years of age and older. COVID-19 mRNA vaccine BNT162b2 has been included in the government vaccination programs in Hong Kong SAR and Macao SAR. As of 27 November 2021, more than 13.5 million doses of COVID-19 mRNA vaccine BNT162b2 have been administered in Hong Kong, Macao and Taiwan. Among them, more than 69,000 people in Hong Kong SAR and Macao SAR have received the third dose of COVID-19 mRNA vaccine BNT162b2.

 

The COVID-19 pandemic is still spreading globally. The Omicron variant poses new challenges to the prevention and control. Fosun Pharma actively promotes academic communications on public health in the Greater Bay Area. Earlier, at the “Guangdong-Hong Kong-Macao Greater Bay Area Public Health Technology Innovation Work Seminar” hosted by the Guangdong Preventive Medicine Association and organized by Fosun Pharma, a number of public health experts and scholars from the Guangdong-Hong Kong-Macao Greater Bay Area shared their views on the COVID-19 pandemic prevention and control strategies. Among them, experts and scholars from Hong Kong shared their experience in pandemic prevention, control and COVID-19 treatment. In terms of immunization strategies, Hong Kong has approved the third dose of COVID-19 vaccine for the high-risk populations.

 

Continue to deepen the layout of healthcare services in the Greater Bay Area, helping to achieve Healthy China 2030

 

According to the deployment of the “‘Healthy China 2030’ blueprint“: By 2030, the institutional system for promoting health for all will be improved, the development of the health field will be more coordinated, healthy lifestyles will be popularized, and the quality of health services and health protection will continue to improve.” The Guangdong-Hong Kong-Macao Greater Bay Area is one of the most open and economically dynamic regions in China, and plays a strategic role in national development.

 

Under the guidance of the national strategies of Healthy China 2030 and Innovation Driven, Fosun Health has gone through many years of intensive industrial cultivation, it has owned and operated many for-profit general hospitals with advantages in brand and medical capabilities in Greater Bay Area, such as Foshan Fosun Chancheng Hospital (referred to as “Foshan Chancheng Hospital”), Shenzhen Heng Sheng Hospital, Zhuhai Chancheng Hospital and Guangzhou Xinshi Hospital. While deepening the layout, Fosun Health integrates the advantages of its member hospitals, focuses on building an international quality and safety system, strengthens the construction of disciplines and specialist alliances, strengthens technological innovation and high-level clinical technology innovation, and consolidates hard strength.

 

Meanwhile, Fosun Health actively promotes the rational allocation and optimization of medical resources such as the doctor group. In talent training, through the Great Health Management College, Fosun Health could train innovative management talents for the Greater Bay Area and even for the domestic healthcare industry. In the era of digital transformation, while strengthening the construction of smart hospitals in the Greater Bay Area, Fosun Health also uses online and offline medical to promote corporate cloud medical office services and achieve full coverage of 500 companies in the Greater Bay Area.

 

Foshan Chancheng Hospital, the flagship Hospital of Fosun Health, also participated in the BEYOND Expo. As a 3A hospital ranking No. 1 in the China Non-Public Hospital Comprehensive Competitiveness and certified by the Joint Commission International (JCI) Accreditation Standards for Hospitals, Foshan Chancheng Hospital, headed by its “Three Treasures of Chancheng Hospital” (intervertebral disc, stone removal, and birth), has set up a series of specialties such as the heart center, the brain center, and the “Zen” anti-aging medicine center to realize technology and service dual wheel drive.

 

In addition, in the field of medical devices, Fosun Pharma has systematically deployed three major business divisions with medical cosmetology, respiratory care, and professional medical care. Adhering to the customer as the core and to the global consumer wellness eco-system strategy, and continuing to strengthen the construction of the international marketing system, Fosun Pharma actively promotes the landing of a number of world-leading medical technologies and cutting-edge medical equipment in China.

 

At the BEYOND Expo, Sisram Medical, the global leading provider of energy-based surgical and medical aesthetics solutions, and Breas, the famous European ventilator brand, as well as the ultra-light and ultra-small CPAP portable ventilator Z1 Auto, are well presented.

 

At the same time, as a locally-incubated medical artificial intelligence company, Fosun Aitrox also brings its medical, digital and intelligent integrated solution, which uses big data and deep learning to build breakthrough intelligent applications to achieve the integration of artificial intelligence in multiple medical departments. The collaborative application from different medical departments could improve the efficiency, and truly realize AI-driven medical technology services.

 

About Fosun Pharma

Founded in 1994, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”; stock code: 600196.SH, 02196.HK) is a leading innovation-driven international healthcare group in China. Fosun Pharma strategically operates businesses in the pharmaceutical and health industry, including pharmaceutical manufacturing, medical devices and medical diagnosis, and healthcare services. Through equity participation in Sinopharm Co., Ltd., Fosun Pharma’s business extends to pharmaceutical distribution and retail.

Fosun Pharma takes pharmaceutical manufacturing as its core business and sticks to innovative research and development. Through in-house R&D, co-development, in-licensing and incubation, Fosun Pharma had established platforms for small molecule innovative drugs, antibody drugs and cell therapy, focusing on major therapeutic areas, including oncology, immunology, “4 hypers” (hypertension, hyperlipidemia, hyperglycemia and hyperuricemia) and their complications, as well as central nervous system. In the meantime, Fosun Pharma keeps close track of cutting-edge technologies, such as targeted protein degradation, RNA, oncolytic virus and gene therapy to enhance its innovation ability.

Looking forward, under guidance of 4IN strategy (Innovation, Internationalization, Integration and Intelligentization), Fosun Pharma practices innovation and transformation, integrated operation and steady development, as well as the concept of sustainable development. Fosun Pharma is committed to becoming the first-class enterprise in the global mainstream healthcare industry.

For more information, please visit: www.fosunpharma.com.

#FosunPharma

Fosun Pharma Forward-looking statements:

This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release, including, without limitation, the discussions of the Company’s business strategies and expectations concerning future operations, margins, profitability, liquidity and capital resources, the future development of the Company’s industry and the future development of the general economy of the Company’s key markets and any statements preceded by, followed by or that include words and expressions such as “expect”, “seek”, “believe”, “plan”, “intend”, “estimate”, “project”, “anticipate”, “may”, “will”, “would” and “could” or similar words or statements, as they relate to the Company or its management, are intended to identify forward-looking statements. These statements are subject to certain known and unknown risks, uncertainties and assumptions, which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Accordingly, you should not place undue reliance on any forward-looking information. Subject to the requirements of applicable laws, rules and regulations, the Company does not have any and undertakes no obligation to update or otherwise revise the forward- looking statements in this press release, whether as a result of new information, future events or developments or otherwise. In this press release, statements of or references to the Company’s intentions are made as of the date of this press release. Any such intentions may change in light of future developments. All forward-looking statements contained in this press release are qualified by reference to the cautionary statements set out above.